BackInMed Pharmaceuticals Overview

InMed Pharmaceuticals Total Assets

Latest total assets for INM: $1.3B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$1.31B
↓ 90.23% YoYΔ $-12.06B vs prior year quarter

Peer trimmed avg / median

Loading

InMed Pharmaceuticals Total Assets History

Loading

InMed Pharmaceuticals vs. peers: Total Assets Comparison

Loading

InMed Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

InMed Pharmaceuticals (INM) FAQ

As of the most recent data (September 2026), INM shows a total assets of $1.3B. That compares with $13B in the prior-year period — down 90.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INM's total assets is now $1.3B (was $13B) — a 90.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether InMed Pharmaceuticals is outperforming or lagging.

Tracking INM's total assets over time shows whether InMed Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3B That compares with $13B in the prior-year period — down 90.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has InMed Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $1.3B) with ownership activity and broader fundamentals.

InMed Pharmaceuticals's total assets is $1.3B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.